The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
The role of cortical inhibition in the pathophysiology and treatment of schizophrenia
Abstract
Dysfunctional cortical inhibition (CI) has been suggested as a mechanism through which symptoms of schizophrenia (SCZ) are mediated. Cortical inhibition refers to a neurophysiological process in which gamma-aminobutyric acid (GABA) inhibitory interneurons selectively attenuate the activity of other neurons (e.g., pyramidal neurons) in the cortex. Here we review the neuroanatomic and neurophysiological evidence suggesting CI deficits among persons with SCZ. We also review genetic studies that have linked CI deficits to a polymorphism in the alpha(7)-nicotinic cholinergic receptor, thereby positing that a specific genetic mechanism underlies SCZ-related GABA interneuron dysfunction. We will conclude by reviewing the role of CI as a mechanism mediating the therapeutic action of antipsychotic medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a variety of evidence exists indicating subtle cortical hyperexcitability in patients with schizophrenia”
From Perineuronal nets and schizophrenia: The importance of neuronal coatings (2014) · cites this paper as Daskalakis et al., 2007
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Baron, R. M., & Kenny, D. A. (1986) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.51.6.1173 · Cited by 91,532
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
The Organization of Behavior: A Neuropsychological Theory
(1950) · JAMA · doi:10.1001/jama.1950.02910470083028 · Cited by 4,272
Corticocortical inhibition in human motor cortex.
Kujirai, T., Caramia, M. D., Rothwell, J. C., Day, B. L., Thompson, P. D., Ferbert, A., Wroe, S. J., Asselman, P., & MARSDEN, C. D. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019912 · Cited by 3,132
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Oscillatory gamma activity in humans and its role in object representation
Tallon‐Baudry, C. (1999) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(99)01299-1 · Cited by 2,205
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation
Chen, R., Classen, J., Gerloff, C., Celnik, P., Wassermann, E. M., Hallett, M., & Cohen, L. G. (1997) · Neurology · doi:10.1212/wnl.48.5.1398 · Cited by 2,128
Research works printed but not linked: 5
- Benes, 1997, Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain, Synapse, 25, 80, 10.1002/(SICI)1098-2396(199701)25:1<80::AID-SYN10>3.0.CO;2-2 · DOI
- Javitt, 2006, Role of NMDA and GABAB receptors in cortical and subcortical dopaminergic regulation, vol. 31, S47
- Leonard, 1998, Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative, Am. J. Med. Genet., 81, 308, 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P · DOI
- Stassen, 2000, Schizophrenia and smoking: evidence for a common neurobiological basis?, Am. J. Med. Genet., 96, 173, 10.1002/(SICI)1096-8628(20000403)96:2<173::AID-AJMG10>3.0.CO;2-U · DOI
- Ziemann, 1996, Impaired motor cortex inhibition in patients with Parkinson's disease and other parkinsonian syndromes. A transcranial magnetic stimulation study [abstract], Mov. Disord., 11, 72
Cited by
Sorted by citations
Howes, O. D., & Shatalina, E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.017 · Cited by 279
Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia
Spencer, K. M., Niznikiewicz, M. A., Nestor, P. G., Shenton, M. E., & McCarley, R. W. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-85 · Cited by 253
Alteration of cortical excitability in patients with fibromyalgia
Mhalla, A., de Andrade, D. C., Baudic, S., Perrot, S., & Bouhassira, D. (2010) · Pain · doi:10.1016/j.pain.2010.03.009 · Cited by 225
Development of the GABAergic System from Birth to Adolescence
Kilb, W. (2012) · The Neuroscientist · doi:10.1177/1073858411422114 · Cited by 190
Radhu, N., de Jesus, D. R., Ravindran, L. N., Zanjani, A., Fitzgerald, P. B., & Daskalakis, Z. J. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.01.014 · Cited by 186
Hierarchical Organization of Gamma and Theta Oscillatory Dynamics in Schizophrenia
Kirihara, K., Rissling, A. J., Swerdlow, N. R., BRAFF, D. L., & Light, G. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.016 · Cited by 184
Epigenetic mechanisms in schizophrenia
Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.009 · Cited by 176
Baseline gamma power during auditory steady-state stimulation in schizophrenia
M. Spencer, K. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2011.00190 · Cited by 155
The neurobiology of methamphetamine induced psychosis
Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00537 · Cited by 160
Bhandari, A., Radhu, N., Farzan, F., Mulsant, B. H., Rajji, T. K., Daskalakis, Z. J., & Blumberger, D. M. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.05.363 · Cited by 172
Evidence for GABAergic inhibitory deficits in major depressive disorder
Croarkin, P. E., LEVINSON, A. J., & Daskalakis, Z. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.002 · Cited by 160
Kammers, M. P. M., Verhagen, L., Dijkerman, H. C., Hogendoorn, H., de Vignemont, F., & Schutter, D. J. L. G. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21095 · Cited by 144
Structural and metabolic changes in language areas linked to formal thought disorder.
Horn, H., Federspiel, A., Wirth, M., Müller, T. J., Wiest, R., Wang, J.-J., & Strik, W. (2009) · The British journal of psychiatry : the journal of mental science · doi:10.1192/bjp.bp.107.045633 · Cited by 124
Gamma oscillations in schizophrenia: Mechanisms and clinical significance
Sun, Y., Farzan, F., Barr, M. S., Kirihara, K., Fitzgerald, P. B., Light, G. A., & Daskalakis, Z. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.065 · Cited by 123
NCAM in Neuropsychiatric and Neurodegenerative Disorders
Brennaman, L. H., & Maness, P. F. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1170-4_19 · Cited by 111
Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Inan, M., Petros, T. J., & Anderson, S. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 105
Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia
Radhu, N., Dominguez, L. G., Farzan, F., Richter, M. A., Semeralul, M. O., Chen, R. E., Fitzgerald, P. B., & Daskalakis, Z. J. (2014) · Brain · doi:10.1093/brain/awu360 · Cited by 106
Perineuronal nets and schizophrenia: The importance of neuronal coatings
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.018 · Cited by 95
Spencer, K. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.033.2009 · Cited by 102
Neuregulin signaling, cortical circuitry development and schizophrenia
Rico, B., & Marín, Ó. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.010 · Cited by 92
Meditation-Related Increases in GABAB Modulated Cortical Inhibition
Guglietti, C. L., Daskalakis, Z. J., Radhu, N., Fitzgerald, P. B., & Ritvo, P. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.08.005 · Cited by 83
Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry
Croarkin, P. E., Wall, C. A., & Lee, J. C. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.623688 · Cited by 79
Nácher, J., Guirado, R., & Castillo-Gómez, E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0977-4 · Cited by 76
Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats
François, J., Ferrandon, A., Koning, E., Angst, M.-J., Sandner, G., & Nehlig, A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009985 · Cited by 68
Determining optimal rTMS parameters through changes in cortical inhibition
de Jesus, D. R., Favalli, G. P. D. S., Hoppenbrouwers, S. S., Barr, M. S., Chen, R. E., Fitzgerald, P. B., & Daskalakis, Z. J. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.09.011 · Cited by 71
Astrocytes—The Ultimate Effectors of Long-Range Neuromodulatory Networks?
Pacholko, A. G., Wotton, C. A., & Bekar, L. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581075 · Cited by 58
Auditory gating deficit to human voices in schizophrenia: A MEG study
Hirano, Y., Hirano, S., Maekawa, T., Obayashi, C., Oribe, N., Monji, A., Kasai, K., Kanba, S., & Onitsuka, T. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.003 · Cited by 53
Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
Kim, H. K., Blumberger, D. M., & Daskalakis, Z. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00795 · Cited by 53
Wędzony, K., & Chocyk, A. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70161-6 · Cited by 50
Yeh, T., Correll, C. U., Yang, F., Chen, M., Tseng, P., Hsu, C., Carvalho, A. F., Stubbs, B., Thompson, T., Chu, C., et al. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103375 · Cited by 51
Pirotta, S., Kidgell, D. J., & Daly, R. M. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2855-6 · Cited by 51
Nilsson, S. R. O., Celada, P., Fejgin, K., Thelin, J., Nielsen, J., Santana, N., Heath, C. J., Larsen, P. H., Nielsen, V., Kent, B. A., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4265-2 · Cited by 53
Radant, A. D., Dobie, D. J., Calkins, M. E., D, A. O. M., BRAFF, D. L., Cadenhead, K. S., Freedman, R., Green, M. F., Greenwood, T. A., Gur, R. E., et al. (2010) · Psychophysiology · doi:10.1111/j.1469-8986.2010.01004.x · Cited by 52
Castillo-Gómez, E., Varea, E., Blasco‐Ibáñez, J. M., Crespo, C., & Nácher, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029516 · Cited by 45
Neurobiological Background for the Development of New Drugs in Schizophrenia
Lopez-Munoz, F. J., & Álamo, C. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318215c2f7 · Cited by 45
Bhandari, A., Voineskos, D., Daskalakis, Z. J., Rajji, T. K., & Blumberger, D. M. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00045 · Cited by 43
Castillo-Gómez, E., Gómez‐Climent, M. Á., Varea, E., Guirado, R., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.018 · Cited by 42
Synapse Loss in Olfactory Local Interneurons Modifies Perception
Acebes, Á., Martín‐Peña, A., Chevalier, V., & Ferrús, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5046-10.2011 · Cited by 42
On the estimation of silent period thresholds in transcranial magnetic stimulation
Kallioniemi, E., Säïsänen, L., Könönen, M., Awiszus, F., & Julkunen, P. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.03.012 · Cited by 40
Kvajo, M., McKellar, H., & Gogos, J. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.051 · Cited by 40
Takahashi, S., Ukai, S., Kose, A., Hashimoto, T., Iwatani, J., Okumura, M., Tsuji, T., & Shinosaki, K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.033 · Cited by 36
Cognitive behavioral therapy-related increases in cortical inhibition in problematic perfectionists
Radhu, N., Daskalakis, Z. J., Guglietti, C. L., Farzan, F., Barr, M. S., Arpin-Cribbie, C. A., Fitzgerald, P. B., & Ritvo, P. (2012) · Brain Stimulation · doi:10.1016/j.brs.2011.01.006 · Cited by 30
Self-citationDolfus, S., LARMURIERMONTAGNE, A., Razafimandimby, A., Delcroix, N., Dolfus, S., LARMURIERMONTAGNE, A., Allio, G., MEMBREY, J., & Etard, O. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.012 · Cited by 32
Berger, B. E., Minarik, T., Griesmayr, B., Stelzig-Schöler, R., Aichhorn, W., & Sauseng, P. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00705 · Cited by 34
Radhu, N., Ravindran, L. N., LEVINSON, A. J., & Daskalakis, Z. J. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120003 · Cited by 34
Du, X. M., Choa, F., Chiappelli, J., Wisner, K., Wittenberg, G. F., Adhikari, B. M., Bruce, H. A., Rowland, L. M., Kochunov, P. V., & Hong, L. E. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.007 · Cited by 31
Croarkin, P. E., Wall, C. A., Nakonezny, P. A., Close, J. S., Husain, M. M., Sampson, S. M., Emslie, G. J., & Kozel, F. A. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0054 · Cited by 31
Comprehensive behavioural intervention for tics: a neurophysiological intervention
Eapen, V., Črnčec, R., Pick, A. X., Tsao, O., Lai, R., Lee, J., & Sowman, P. F. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2103089 · Cited by 27
Exploring causal mechanisms of psychosis risk
Oliver, D., Chesney, E., Cullen, A. E., Davies, C., Englund, A., Gifford, G., Kerins, S., Lalousis, P. A., Logeswaran, Y., Merritt, K., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105699 · Cited by 33
Dhami, P., Moreno, S., Croarkin, P. E., Blumberger, D. M., Daskalakis, Z. J., & Farzan, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-45107-1 · Cited by 26
Asmus, S. E., Anderson‐Baucum, E. K., Ball, M. W., Barnes, B. A., Bohnen, A. M., Brown, A. M., Hartley, L. J., Lally, M. C., Lundblad, T. M., Martin, J., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.053 · Cited by 26
Jeng, J., Li, C., Lin, H., Tsai, S., Bai, Y., Su, T., Chang, Y.-W., & Cheng, C. (2019) · Psychological Medicine · doi:10.1017/s0033291719001223 · Cited by 27
Hahn, M., Cohn, T. A., Teo, C., & Remington, G. J. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.haco.01062013 · Cited by 24
Silver, H., Chertkow, Y., Weinreb, O., Danovich, L., & Youdim, M. B. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.034 · Cited by 26
The use of theta burst stimulation in patients with schizophrenia – A systematic review
Poorganji, M., Göke, K., Zomorrodi, R., Voineskos, D., Rajji, T. K., Daskalakis, Z. J., & Blumberger, D. M. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.005 · Cited by 22
Verdurand, M., Fillman, S. G., Weickert, C. S., & Zavitsanou, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052724 · Cited by 21
Millan, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00001-1 · Cited by 22
Ritvo, P., Vora, K., Irvine, J., Mongrain, M., Azargive, S., Azam, M. A., Pirbaglou, M., Guglietti, C., Wayne, N., Perez, D., et al. (2013) · International Journal of Educational Psychology · doi:10.4471/ijep.2013.28 · Cited by 18
Fatih, P., Küçüker, M. U., Voort, J. L. V., Camsari, D. D., Farzan, F., & Croarkin, P. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678088 · Cited by 20
Kaul, D., Schwab, S. G., Mechawar, N., Ooi, L., & Matosin, N. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2410-21.2022 · Cited by 24
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c002f · Cited by 19
Maćkowiak, M., Dudys, D., Chocyk, A., & Wędzony, K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.10.001 · Cited by 19
Andrews, S. C., Enticott, P. G., Hoy, K. E., Thomson, R. H., & Fitzgerald, P. B. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1029140 · Cited by 19
Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis
Tang, Y., Zhang, T., Edelman, B. J., Zeng, B., Zhao, S., Li, C., Zhuo, K., Qian, Z., Li, H., Guo, Q., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.004 · Cited by 18
Lawn, T., Giacomel, A., Martins, D., Veronese, M., Howard, M. A., Turkheimer, F., & Dipasquale, O. (2024) · Communications Biology · doi:10.1038/s42003-024-06391-3 · Cited by 22
Developmental GABAergic deficit enhances methamphetamine-induced apoptosis
Abekawa, T., Ito, K., Nakato, Y., & Koyama, T. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2269-5 · Cited by 17
The role of white matter microstructure in inhibitory deficits in patients with schizophrenia
Du, X. M., Kochunov, P., Summerfelt, A. T., Chiappelli, J., Choa, F., & Hong, L. E. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.11.006 · Cited by 14
Schutter, D. J. L. G., & van Honk, J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.009 · Cited by 14
Consciousness, schizophrenia and complexity
Bob, P. (2011) · Cognitive Systems Research · doi:10.1016/j.cogsys.2011.05.001 · Cited by 13
The contribution of gamma bursting to spontaneous gamma activity in schizophrenia
Spencer, K., Nakhnikian, A., Hirano, Y., & Levin, M. E. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1130897 · Cited by 12
Asmus, S. E., Cocanougher, B., Allen, D. L., Boone, J. B., Brooks, E. A., Hawkins, S. M., Hench, L. A., Ijaz, T., & Mayfield, M. N. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.101 · Cited by 12
Filho, V. A. M., de Jesus, D. R., Belmonte-de-Abreu, P. S., Cachoeira, C. T., & Lobato, M. I. R. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.031 · Cited by 12
Goodman, M. S., Bridgman, A. C., Rabin, R. A., Blumberger, D. M., Rajji, T. K., Daskalakis, Z. J., George, T. P., & Barr, M. S. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.11.004 · Cited by 12
NCAM in Neuropsychiatric and Neurodegenerative Disorders
Brennaman, L. H., & Maness, P. F. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9630-z · Cited by 12
Daskalakis, A. A., Zomorrodi, R., Blumberger, D. M., & Rajji, T. K. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.030 · Cited by 11
A Network Model of the Modulation of γ Oscillations by NMDA Receptors in Cerebral Cortex
Susin, E., & Alain Destexhe, A. (2023) · eNeuro · doi:10.1523/eneuro.0157-23.2023 · Cited by 11
EEG Complexity and Attentional Processes Related to Dissociative States
Bob, P., Golla, M. A., Epstein, P., & Konopka, L. M. (2011) · Clinical EEG and Neuroscience · doi:10.1177/155005941104200306 · Cited by 10
Multi-target Therapy for Subcellular Incompatibility in Brain Disorders
Wang, J., & Cui, S. (2015) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000200 · Cited by 8
Nathou, C., Etard, O., Simon, G., & Dollfus, S. (2014) · Psychophysiology · doi:10.1111/psyp.12323 · Cited by 7
Co-Regulation and Epigenetic Dysregulation in Schizophrenia and Bipolar Disorder
Zelena, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_10 · Cited by 7
Schuler, A., Tik, M., Kallioniemi, E., Marti, A. S., Cai, Z., & Pellegrino, G. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106338 · Cited by 6
Fernández‐Linsenbarth, I., Mijancos-Martínez, G., Bachiller, A., Nùñez, P., Rodríguez-González, V., Beño‐Ruiz‐de‐la‐Sierra, R. M., Roig-Herrero, A., Arjona, A., Poza, J., Mañanas, M. Á., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01745-0 · Cited by 5
Kallioniemi, E., Säïsänen, L., Pitkänen, M., Könönen, M., Karhu, J., & Julkunen, P. (2015) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000177 · Cited by 4
Splitting in Schizophrenia: Controversies and Links Between Neuroscience and Psychodynamic Theory
Bob, P., & Pěč, O. (2017) · Activitas Nervosa Superior · doi:10.1007/s41470-017-0012-1 · Cited by 4
Asmus, S. E., Raghanti, M. A., Beyerle, E. R., Fleming-Beattie, J. C., Hawkins, S. M., McKernan, C., & Rauh, N. A. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.07.007 · Cited by 3
Early Integration Processing between Faces and Vowel Sounds in Human Brain: An MEG Investigation
Nakamura, I., Hirano, Y., Ohara, N., Hirano, S., Ueno, T., Tsuchimoto, R., Kanba, S., & Onitsuka, T. (2015) · Neuropsychobiology · doi:10.1159/000377680 · Cited by 3
Kehne, J. H., & Maynard, G. D. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch15 · Cited by 3
Methamphetamine-Induced Behavioral Abnormalities and Neuronal Apoptosis
Abekawa, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00013-3 · Cited by 2
Lawn, T., Giacomel, A., Martins, D., Veronese, M., Howard, M. A., Turkheimer, F., & Dipasquale, O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.21.563428 · Cited by 2
Wang, L., Zhang, J., Geng, L., Chen, B., Li, J., Xu, Y., & Wang, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03388-0 · Cited by 1
The Contribution of Tonic Inhibition to Cognitive Deficits in a Mouse Model of Bipolar Disease
Vacca, N. A. (2024) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.557 · Cited by 1
Skog, H., Määttä, S., Säïsänen, L., Lakka, T. A., & Haapala, E. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1297009 · Cited by 1
Владимировна, Ч. Т. (2011) · Психологические исследования · doi:10.54359/ps.v4i15.868 · Cited by 1
Biochemical alterations in schizophrenia
Glenthoj, B. Y., Kristiansen, L. V., Rasmussen, H., & Oranje, B. (2009) · CRC Press eBooks · doi:10.3109/9781420080063-13 · Cited by 1
Examining the Cortical Phenomena of Psychiatric Disorders using Transcranial Magnetic Stimulation
Ravindran, L. N., Radhu, N., & Daskalakis, Z. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-32767-4_16
Korostenskaja, M. (2008) · Työväentutkimus Vuosikirja
Hiperactivacion cortical y deterioro cognitivo en esquizofrenia
Bonnelly, S., & Vanessa, J. (2014) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Leppä, E. (2011) · Työväentutkimus Vuosikirja
Dael, F. W. J. J. V. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20141204fv
Inhibition of Gamma Oscillations in Healthy Subjects and Patients with Schizophrenia
Farzan, F. (2011) · TSpace (University of Toronto)
Metadata
- Authors
- Daskalakis, Z. J., Fitzgerald, P. B., & Christensen, B. K.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- The Alfred Hospital (AU)
- Corresponding author
- Daskalakis, Zafiris J.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 56
- Issue
- 2
- Pages
- 427-442
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2083937777
- Cited by
- 111
- References
- 151
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 9 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 9
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
- Keywords
- cortical inhibition, schizophrenia, GABAergic interneurons, alpha7 nicotinic acetylcholine receptor, genetic polymorphism, antipsychotic mechanism of action, pyramidal neurons, schizophrenia pathophysiology, schizophrenia treatment
- MeSH terms
- Animals, Cerebral Cortex, gamma-Aminobutyric Acid, Humans, Interneurons, Schizophrenia, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review